Name

CI-1033

Alternate Names

CI 1033
CI1033

Abbreviations

None

Category

Chemotherapy

Subcategory

Cytostatic agent--dual inhibitor

NSC Number

None

Primary Site

Breast
head & neck
lung cancer

Histology

None

Remarks

Phase II Erb-b2 and EGFR dual kinase inhibitor. Pfizer, NCI.

Coding

This drug should be coded
Glossary